RadNet, Inc. Common Stock (RDNT) Stock Price
RDNTStock
$68.80−11.10%52W
Market Cap$5.41B
P/E1779.27x
PEG Ratio0.96
Div yield—
Beta1.44
RDNT Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)9.21%
Price vs S&P 500 (4W)-4.00%
PEG Ratio0.96
VGM Score41.59
P/E Ratio (Annual)1779.27x
RDNT Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.20 | $0.29 | +43.97%(+$0.09) | |
| Q1 2026 | -$0.19 | -$0.28 | -46.08%(-$0.09) | |
| Q4 2025 | $0.20 | $0.23 | +12.59%(+$0.03) | |
| Q3 2025 | $0.23 | $0.20 | -11.77%(-$0.03) | |
| Q2 2025 | $0.16 | $0.31 | +97.87%(+$0.15) |
RDNT Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.29
4.29
4.29
4.29
Industry Peers — Health Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
RDNTRadNet, Inc. Common Stock | D | C | C | 1779.3x | 18.9% | 3.0% | -1.9% | $68.80 |
| NTRANatera, Inc. Common Stock | F | A | A | — | 37.8% | -10.7% | -11.7% | $393.44 |
| DGXQuest Diagnostics Inc. | C | D | B | 26.1x | 9.9% | 14.1% | 14.5% | $235.00 |
| LHLabcorp Holdings Inc. | C | D | B | 29.4x | 6.4% | 10.4% | 11.6% | $317.95 |
| GHGuardant Health, Inc. Common Stock | F | A | B | — | 42.7% | -40.2% | -246.6% | $158.60 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | B | — | 38.5% | 12.7% | 18.8% | $30.56 |
| GRALGRAIL, Inc. Common Stock | D | B | B | — | 23.1% | -338.4% | -15.9% | $117.81 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | C | 621.1x | — | 10.9% | 8.9% | $98.12 |
| VCYTVeracyte, Inc. | D | B | C | 52.2x | 17.3% | 19.6% | 8.6% | $43.12 |
| CDNACareDx, Inc. | D | B | A | 18.3x | 34.4% | 23.6% | 32.8% | $64.00 |
| CELCCelcuity Inc. Common Stock | — | — | D | — | — | — | -244.6% | $56.58 |
About RadNet, Inc. Common Stock
RadNet Inc operates a national network of diagnostic imaging centers offering MRI, CT, PET, nuclear medicine, mammography, and other imaging services. The company's Digital Health segment develops clinical applications for medical image interpretation and patient outcomes, with specialized focus on brain, breast, prostate, and pulmonary diagnostics.